Sentir

Instrument Exit Point on Touch Surgery™ Aide

Covidien, LLC · K253984

FDA-authorized Predetermined Change Control Plan

1 of 70 AI/SaMD1 of 4 in Gastroenterology, Urologyauthorized 2026
Company
Covidien, LLC
510(k)/De Novo #
K253984
Decision date
2026-06-04
Panel
Gastroenterology, Urology
Pathway
510(k)
Category
AI/SaMD
PCCP type
Unknown
Monitoring commitment
Unknown

Browse

Other Gastroenterology, Urology PCCPs

Want the monitoring teardown?

We read the PCCP for Instrument Exit Point on Touch Surgery™ Aide, then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.

Book a call

Source: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.

This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.